What does Roche do?
ROCHE is a global leader in healthcare, specializing in pharmaceuticals and diagnostics. The company focuses on developing innovative treatments and diagnostic tools to improve patient outcomes. With a strong commitment to research and development, ROCHE aims to address unmet medical needs worldwide.
- Sectors
- Wholesalers
- Activities
- Signals
-
High social debt vs. personnel costsHigh social debt vs. personnel costs 27.9%
Social debts are a high share of personnel costs, which may indicate social security arrears.
ProfitableProfitable € 8.74MThe company reported a positive net result in the latest financial year.
Strong equityStrong equity € 64.46MStrong equity provides a buffer against setbacks.
Low riskLow risk 39.1%Good solvency (> 30%) points to long-term financial stability.
Good liquidityGood liquidity 1.62A healthy current ratio (≥ 1.5): enough current assets to cover short-term debt.
Positive cashflowPositive cashflow € 8.64MPositive operating cash flow in the latest financial year.
Positive EBITDAPositive EBITDA € 14.41MPositive EBITDA: operating activities are profitable.
High turnoverHigh turnover € 448.79MSubstantial turnover in the latest financial year.
Financial ratios
|
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
€
448.79M
|
€
451.21M
|
€
421.00M
|
€
403.34M
|
|
|
€
14.41M
|
€
12.53M
|
€
9.05M
|
€
10.55M
|
|
|
€
8.74M
|
€
7.88M
|
€
8.86M
|
€
8.61M
|
|
|
€
64.46M
|
€
55.72M
|
€
69.83M
|
€
60.97M
|
|
|
39.13%
|
29.26%
|
36.89%
|
38.01%
|
|
|
€
97.75M
|
€
130.11M
|
€
114.74M
|
€
92.58M
|
|
|
|
-
|
€
46.60M
|
€
50.15M
|
|
|
123.30
|
127.70
|
135.60
|
93.90
|
Publications 159
All publications- Ontslagen - Benoemingen 27/08/2026
- Ontslagen - Benoemingen 28/11/2025
- Ontslagen - Benoemingen 31/01/2025
- Ontslagen - Benoemingen 18/07/2024
- Ontslagen - Benoemingen 19/04/2024
News
Show all- Sentara Williamsburg Lights Up For Metastatic Breast Cancer Awareness Daily Press 1 week ago
- The 10 Best Walmart Deals To Shop This Week: Bissell, La Roche Posay, Stanley And More CNN 1 week ago
- Negative Nice Final Guidance For Roche’s Itovebi The Pharma Letter 1 week ago
- Nice Does Not Recommend Itovebi Regimen In Advanced Breast Cancer GenomeWeb 1 week ago
- Roche Maintained At Buy As Bofa Notes Bullish View On Giredestrant marketscreener.com 1 week ago
Frequently asked questions
Answers to the most common questions about Roche, based on official government data and the filed annual accounts.
What is the VAT number of Roche?
The VAT number of Roche is BE0403.088.151.
What is the official website of Roche?
The official website of Roche is http://www.roche.com/.
How many employees work at Roche?
In 2025, Roche employed 123.30 full-time equivalents (FTE).
When was Roche established?
Roche was founded in 12-02-1924.
What is the official address of Roche?
The official address of Roche is Dantestraat 75 Anderlecht 1070.
What is the legal form of Roche?
The juridical form of Roche is Public limited company (NV/SA).
What is the annual revenue of Roche?
The revenue of Roche for the 2025 financial year was €448,791,077.
What does Roche do?
ROCHE is a global leader in healthcare, specializing in pharmaceuticals and diagnostics. The company focuses on developing innovative treatments and diagnostic tools to improve patient outcomes. With a strong commitment to research and development, ROCHE aims to address unmet medical needs worldwide.
Is Roche a reliable company?
Roche is a registered Rechtspersoon with company number 0403.088.151 and can be verified through the official CBE database.
What is the credit limit of Roche?
The estimated credit limit of Roche is €10,000,000.
Is Roche still active?
Roche currently has the status "Normal situation" and is active.